The Hospital for Sick Children and St Michael's Hospital to Evaluate Innovotech's bioFILM PA(TM) Test
July 29 2008 - 7:00AM
Marketwired
EDMONTON, ALBERTA is pleased to announce a three year study by
the Hospital for Sick Children and St. Michael's Hospital to
evaluate bioFILM PA(TM), Innovotech's novel biofilm antimicrobial
susceptibility test, in the selection of antibiotics to treat lung
infections in cystic fibrosis patients.
"bioFILM PA(TM) is a Health Canada registered product, and is
therefore available for use by physicians and diagnostic
laboratories in the treatment of a host of biofilm respiratory
infections" says Dr Bhavin Rawal, Product Manager, Innovotech. "Our
early results in cystic fibrosis show promise, so it is appropriate
to continue the evaluation of bioFILM PA(TM), particularly with the
Hospital for Sick Children and St Michael's Hospital, given their
international reputation in this field."
Dr Valerie Waters, Infectious disease physician, Dr Yvonne Yau,
Clinical microbiologist, from the Hospital for Sick Children, and
Dr Elizabeth Tullis, Head, Division of Respirology, St Michael's
Hospital, will evaluate bioFILM PA(TM) as a diagnostic tool to
improve the treatment of lung disease in cystic fibrosis
patients.
The National Research Council's Industrial Research Assistance
Program (IRAP) has provided funding for the study.
About Innovotech Inc:
Innovotech is a product development company focusing on the
development of solutions to medical, agricultural and industrial
problems caused by microbial biofilms. Biofilms are protected
communities of microorganisms which are very common and very
difficult to treat due to their inherent resistance. They have been
implicated in a host of devastating infections in agriculture,
human health and industry. No diagnostics or antibiotics are
currently approved for use in infections involving biofilms.
The TSX Venture Exchange does not accept responsibility for the
adequacy or accuracy of this release.
Contacts: Innovotech Inc. Wolfgang Muhs CEO (780) 448-0585 ext
226 (780) 424-0941 (FAX) Email: wolfgang.muhs@innovotech.ca
Innovotech Inc. Ken Boutilier President (780) 448-0585 ext 221
(780) 424-0941 (FAX) Email: ken.boutilier@innovotech.ca Website:
www.innovotech.ca
Innovotech (TSXV:IOT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Innovotech (TSXV:IOT)
Historical Stock Chart
From Jul 2023 to Jul 2024
